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The secretion of aspartic proteases (Saps) has long been recognized as a virulence-associated trait of the
pathogenic yeast Candida albicans. In this study, we report that different recombinant Saps, including Sap1,
Sap2, Sap3, and Sap6, have differing abilities to induce secretion of proinflammatory cytokines by human
monocytes. In particular Sap1, Sap2, and Sap6 significantly induced interleukin-1 (IL-1), tumor necrosis
factor alpha (TNF-), and IL-6 production. Sap3 was able to stimulate the secretion of IL-1 and TNF-. All
Saps tested were able to induce Ca2 influx in monocytes. Treatment of these Saps with pepstatin A did not
have any effect on cytokine secretion, indicating that their stimulatory potential was independent from their
proteolytic activity. The capacity of Saps to induce inflammatory cytokine production was also independent
from protease-activated receptor (PAR) activation and from the optimal pH for individual Sap activity. The
interaction of Saps with monocytes induced Akt activation and phosphorylation of IB, which mediates
translocation of NF-B into the nucleus. Overall, these results suggest that individual Sap proteins can induce
an inflammatory response and that this phenomenon is independent from the pH of a specific host niche and
from Sap enzymatic activity. The inflammatory response is partially dependent on Sap denaturation and is
triggered by the Akt/NF-B activation pathway. Our data suggest a novel, activity-independent aspect of Saps
during interactions of C. albicans with the host.
Candida albicans is a generally harmless commensal yeast
that colonizes mucosal surfaces of the gastrointestinal or uro-
genital tract in most healthy people. In severe cases of infec-
tion, C. albicans may reach the bloodstream due to damage of
barriers, for example, after polytrauma or surgery, or via pen-
etration of the gastrointestinal mucosa in susceptible hosts,
thereby causing hematogenously disseminated candidiasis
(31). C. albicans has developed a battery of virulence factors
that enables the fungus to colonize host tissues, to escape the
immune response, and to cause disease (5, 22, 62). A variety of
different virulence factors contribute to the infective process of
the fungus, and these factors can be expressed in either a
qualitative or quantitative manner, depending on the site of
infection, the stage of infection, and the nature of the host
immune response (12, 19).
The secretion of aspartic proteases (Saps), encoded by a
gene family with 10 members, has long been recognized as a
virulence-associated trait of this pathogenic yeast (34, 35). In-
dividual Sap proteases have been purified from C. albicans
culture supernatants (18) or by recombinant expression in
Pichia pastoris (3) or Escherichia coli (24, 25), and their bio-
chemical properties have been characterized (2, 3, 55). For
example, the optimum pHs for individual Saps have been es-
tablished as between pH 2.0 and 5.5 for Saps 1 to 3 and
between pH 3.0 and 7.0 for Saps 4 to 6 (3). Sap9 and Sap10
have been identified as glycosylphosphatidylinositol (GPI)-an-
chored proteases which target proteins necessary for both cel-
lular processes and host-pathogen interactions (1).
The expression of all SAP genes has been monitored in vivo
during interaction with host cells in several studies (10, 37, 46,
49, 56, 57, 60). Furthermore, earlier studies have shown that
Saps are recognized by the host and that anti-Sap antibodies
are produced by patients (47).
The role of C. albicans Saps during human infection has not
been clarified completely. Saps have been described as critical
virulence factors involved in promoting adhesion to, invasion
of, and damage to epithelial cells and tissue (9, 21, 33, 35, 64).
Consistent with this view, it has been reported that the aspartic
protease inhibitor pepstatin A is able to inhibit the invasion of
C. albicans during interaction with oral or intestinal epithelial
cells (9, 36). In addition, inhibiting Sap activity by using pep-
statin A has been shown to reduce human epithelial damage
(27, 36, 52). Furthermore, it has been shown that mutants
lacking Saps 1 to 3 cause a reduced proinflammatory response
of epithelial cells (49, 51). Another report showed that Saps 4
to 6, but not Saps 1 to 3, play an important role in survival and
escape of C. albicans during interaction with macrophages (3).
A more recent study on the cell surface-associated protease
Sap9 showed that this protease can efficiently and rapidly de-
grade the antimicrobial peptide histatin 5, produced by oral
epithelial cells, resulting in the loss of the anti-Candida albi-
cans potency of histatin 5 (32). Another recent report indicates
that deletion of SAP9 leads to a mitigated release of reactive
oxygen intermediates (ROI) by human polymorphonuclear
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leukocytes (PMNs) and decreases C. albicans-induced apopto-
sis triggered by ROI formation (17). Furthermore, Saps 1 to 3
have been shown to mediate evasion of human complement
attack via degradation of complement components (13).
Pathogens initially interact with the innate immune system
via binding between microorganism-specific chemical signa-
tures (pathogen-associated molecular patterns [PAMPs]) and
pattern recognition receptors (PRRs) on antigen-presenting
cells. PAMPs bind specifically to two classes of PRRs, namely,
Toll-like receptors (TLRs) and C-lectin-like receptors. PAMP-
PRR interaction triggers signaling responses that culminate in
release of proinflammatory cytokines. Moreover, it has been
demonstrated that several microbial virulence factors are able
to link PRRs and to activate the proinflammatory response.
Porphyromonas gingivalis fimbriae, a major virulence factor of
this pathogen, are able to link CD14 and CD11b/18, following
which TLRs are recruited as signal receptors (14). The M1
protein of Streptococcus pyogenes binds to TLR2 and TLR4
(54). Both the native mannosylated MP65 protein (a -
glucanase adhesin) and the recombinant protein (rMP65) of
Candida albicans were efficiently bound and taken up by mac-
rophages and dendritic cells in a process involving both clath-
rin-dependent and clathrin-independent mechanisms. More-
over, the RGD sequence is involved in rMP65 uptake, to some
extent. After internalization, rMP65 was partially localized in
lysosomes and resulted in efficient protein degradation and
presentation to CD4 T cells (42).
Serine protease enzymes are able to activate protease-acti-
vated receptors (PARs), a newly identified family of G-pro-
tein-coupled receptors. As a consequence, proteases have the
potential to modulate the inflammatory response (16).
The first cell interaction of foreign antigens with cell surface
receptors leads to the stimulation of signal transduction cas-
cades, starting with phosphatidylinositol 3-kinase (PI3K) acti-
vation, which is one of the most prevalent signal transduction
events, if not the most prevalent event, associated with mam-
malian cell surface receptor activation (15). PI3K recruits
pleckstrin homology domain-containing proteins, including
Akt and phosphoinositide-dependent protein kinase, to the
plasma membrane. The PI3K/Akt signaling cascade is crucial
to widely divergent physiological processes, which include cell
cycle progression, differentiation, transcription, translation,
apoptosis, endocytosis, motility, and metabolism (30).
Given the many roles of C. albicans secreted aspartic pro-
teases during interaction with the host through different mech-
anisms, we questioned whether Saps (i) are able to interact
with PARs and (ii) retain immunomodulatory potential during
interaction with host immune cells. Furthermore, we analyzed
the response of primary human phagocytic cells (monocytes) to
different purified Saps, as well as the biological and molecular
events that accompany this interaction.
MATERIALS AND METHODS
Aspartic protease production. Recombinant C. albicans aspartic proteases
rSap1, rSap2, rSap3, and rSap6 and the Malassezia furfur lipase MfLip1 were
expressed as recombinant proteins by use of Pichia pastoris clones, produced in
our laboratory (MfLip1) or kindly provided by Michel Monod, Lausanne, Swit-
zerland (Sap1, -2, -3, and -6), as previously described (3, 4).
Recombinant proteins were harvested from P. pastoris culture supernatants.
Aspartic proteases were purified via anion-exchange chromatography, followed
by desalting by passage through a Sephadex G25 column, and lipase was con-
centrated using Amicon Ultra-15 centrifugal filter units (Millipore). The activity
of proteases and inhibition by pepstatin A under standard reaction conditions
were verified by using a fluorescence-based casein assay (Molecular Probes). The
culture supernatant was first desalted, and low-molecular-weight solutes were
removed by passage through a Sephadex G25 column (PD10 column; Pharma-
cia), using 10 mM sodium citrate buffer, pH 6.5. The recombinant proteases
Sap1, Sap2, and Sap3 recovered from the first purification step were loaded on
a small polypropylene column filled with 0.5 ml of DEAE-Sepharose (Pharma-
cia), washed with the same buffer, and eluted with 100 mM sodium citrate buffer
at pH 5.0. Sap6 protein recovered from the Sephadex G25 column was loaded on
a hydroxyapatite column (0.1 g in a small polypropylene column). The column
was first washed with 50 mM sodium phosphate buffer (pH 7.0), and the Sap
isoenzymes were eluted with 150 mM sodium phosphate buffer (pH 7.0). The
eluted proteases were further purified through an affinity chromatography system
(EndoTrap; Profos AG) to remove possible endotoxin contamination. After
purification, rSAPs tested negative for endotoxin contamination in a Limulus
assay (E-toxate; Sigma) with a sensitivity of 10 pg/ml of Escherichia coli lipo-
polysaccharide (LPS). Nevertheless, selected experiments were carried out at
least once in the presence of 10 g/ml of polymyxin B (Sigma), a polycationic
antibiotic, to neutralize any undetected contamination with bacterial LPS.
In selected experiments, we used native Sap2 purified as previously described
(29, 58). The Sap2 produced by C. albicans strain 10261, grown in YBD medium
(0.2% yeast extract, 2% glucose, 0.2% bovine serum albumin [BSA]), was puri-
fied by DEAE–Sephadex A-25-120 chromatography and concentrated by ultra-
filtration. The purified enzyme gave one band with a molecular weight of 43,000
in an analysis by SDS-PAGE.
In addition, we also used culture supernatants from C. albicans strains grown
in YCB-BSA and containing high concentrations of native Sap2 as previously
described (20). Briefly, Candida albicans CAF2-1 and CEC987 were pregrown
overnight in SD medium (6.7 g yeast nitrogen base without amino acids and 20 g
glucose per liter) at 30°C and then diluted 1:100 in YCB-BSA medium (23.4 g
yeast carbon base and 4 g BSA per liter). The pH of YCB-BSA medium was
adjusted to 4.0, and the culture was incubated at 30°C for 48 h. The secretomes
from these cultures were used in experiments to stimulate proinflammatory
cytokine secretion by monocytes.
Proteases and LPS were heat inactivated by autoclaving (exposure to 120°C for
20 min).
In selected experiments, the aspartyl protease pepsin from porcine gastric
mucosa (Sigma) was used as a negative control.
Monocyte isolation. Heparinized venous blood was obtained from healthy
donors and diluted with RPMI 1640 (Gibco-BRL). Peripheral blood mononu-
clear cells (PBMC) were separated by density gradient centrifugation over Ficoll-
Hypaque Plus (Pharmacia Biotech, Uppsala, Sweden), recovered, washed twice,
suspended in RPMI 1640 supplemented with 10% fetal calf serum, 100 U
penicillin/ml, and 100 g streptomycin/ml, plated in cell culture flasks (Corning
Incorporated), and incubated for 1 h at a density of 2  106 to 3  106/ml. The
adherent cells recovered were 95% CD14, as evaluated by flow cytometry.
Cytotoxicity assay. Monocytes (2.5  105) were treated with different doses of
recombinant Saps (rSaps) ranging from 1 to 50 g/ml for 4 h and 18 h at 37°C,
and cell viability was evaluated by the use of an ATP bioluminescence kit (Via
Light kit; Cambrex). Briefly, 100 l of each sample was added to a 96-well culture
plate, 50 l of lysis reagent was added to each well, and after 10 min of incuba-
tion, 100 l of ATP monitoring reagent (AMR Plus) was added to each sample.
After 2 min of incubation at room temperature, luminescence was measured by
a luminometer (Infinite 200; Tecan).
Cytosolic calcium determination. The cytosolic calcium level was determined
by using a fluorescent dye as previously described (41, 59). Fura-2 (4 l of a 1
mM solution in dimethyl sulfoxide [DMSO]) was added to monocyte suspensions
(about 30  106 cells) in serum-free medium and incubated for 60 min at 37°C
in the dark. Cells were harvested by centrifugation at 600  g for 10 min and
finally suspended (107 cells/ml) in HBSS (140 mM NaCl, 5.3 mM KCl, 1 mM
MgCl2, 1 mM CaCl2, 5 mM glucose, 25 mM HEPES; pH 7.4). A total of 106 cells
per sample were stimulated with different rSaps (20 g/ml), and the Ca2 level
was determined for the following 90 min. As a positive control, 5 M ionomycin
was added for 10 min to obtain maximal fluorescence. EDTA (10 mM) was
added to chelate the Ca2 from Fura-2 as a negative control. Fluorescence was
measured with a spectrophotofluorimeter (excitation at 380 nm and emission at
510 nm) (Infinite 200; Tecan). Cytosolic calcium concentrations were calculated
as follows: [Ca2]  Kd  (F  Fmin)/(Fmax F), where F is the experimentally
measured fluorescence intensity, Fmin is the measured fluorescence intensity in
the absence of Ca2 (in the presence of EDTA), Fmax is the measured fluores-
cence intensity of Ca2-saturated dye (ionomycin-treated cells), and Kd is the
dissociation constant of Fura-2 (224 nM).
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Determination of proinflammatory cytokine production. Monocytes (2  106/
ml) were incubated with different doses of rSaps, ranging from 1 to 50 g/ml, or
with LPS, ranging from 0.001 to 10 g/ml, for 18 h. As a negative control, a
recombinant protein, lipase (15 g/ml), obtained with the same Pichia pastoris
system, and pepsin (1 to 50 g/ml) were used in selected experiments. In parallel
experiments, monocytic cells were treated with pepstatin A (15 M), polymyxin
B (10 g/ml), or 10 to 50 g/ml of mouse anti-human PAR1 (ATAP2; raised
against amino acids 42 to 55, located inside the tethered ligand domain of
PAR1); mouse anti-human PAR2 (SAM11); a mouse monoclonal IgG2a anti-
body raised against amino acids 37 to 50 (SLIGKVDGTSHVTG), located inside
the human PAR2 cleavage site; or mouse anti-human PAR3 (8E8), raised
against amino acids 31 to 47, which include the cleavage site to inhibit the
enzymatic activity of Saps. To study the role of Akt in the intracellular signaling
activated by proteases, cells were pretreated with 5 M wortmannin for 40 min
before adding Saps. The presence of human tumor necrosis factor alpha (TNF-
), interleukin-1 (IL-1), and IL-6 in culture supernatant fluids was measured
with an enzyme-linked immunosorbent assay (ELISA) kit (BD Biosciences Phar-
mingen).
Protease FITC labeling. Proteases and CTLA-4 F(ab)2 (Ancell) were labeled
with fluorescein isothiocyanate (FITC), using a Fluoro Tag FITC conjugation kit
(Sigma). Briefly, fresh FITC solution in carbonate-bicarbonate buffer was added
to the rSap solutions, and samples were incubated for 2 h at room temperature
with gentle stirring. The labeled proteins were purified from unconjugated flu-
orescein by use of a Sephadex G25 M column.
Protease association with human monocytes. The association of rSaps with
human monocytes was analyzed by flow cytometry. Monocytes were incubated
with different doses of FITC-conjugated rSaps and CTLA-4 F(ab)2 for different
periods at 37°C in the presence of 5% CO2. After incubation, cells were collected
by centrifugation, fixed in 1% paraformaldehyde in phosphate-buffered saline
(PBS), washed twice, and resuspended in PBS containing 0.5% bovine serum
albumin and 0.1% sodium azide. Cells attached to or containing Saps were
monitored using a FACScan flow cytometer (Becton Dickinson). To analyze the
specific association of FITC-labeled proteins in selected experiments, monocytes
were first incubated with unlabeled rSaps (20 g/ml) and then treated with
FITC-conjugated rSAPs at 20 g/ml for 30 min.
Determination of phosphorylated Akt and IB. The levels of Akt and I	B
phosphorylation in monocytes were measured by flow cytometry after 4 h of
stimulation with rSap1, rSap2, rSap3, rSap6, or pepsin (20 g/ml). Phosphory-
lated proteins were detected with rabbit anti-human phospho-I	B or with
rabbit anti-human phospho-Akt (Cell Signaling Technology). Cells were first
fixed in 3% paraformaldehyde for 10 min and then permeabilized in 0.1%
saponin at 4°C for 10 min. Primary antibody incubation was followed by incu-
bation with tetramethyl rhodamine isocyanate (TRITC)-conjugated goat anti-
rabbit IgG (Sigma). Phosphorylation of phospho-I	B or phospho-Akt was
analyzed on a FACScan flow cytometer (BD Biosciences, San Jose, CA).
Statistical analysis. Statistical significance was determined using analysis of
variance (ANOVA). Results are presented as means 
 standard deviations
(SD).
RESULTS
Secreted aspartic proteases (Saps) are important virulence
factors of Candida albicans and may also contribute to the
induction of an inflammatory host immune response (35, 51).
To analyze a possible correlation between Sap secretion and
the host immune response, we used the following recombinant
secreted Saps: rSap1, rSap2, and rSap3, representing the Sap
family subgroup Sap1-3, and rSap6, representing the Sap fam-
ily subgroup Sap4-6. We tested the ability of secreted aspartic
proteases to induce proinflammatory cytokines by coincubat-
ing human monocytes isolated from blood from healthy donors
with the different rSaps. The results shown in Fig. 1A indicate
that human monocytes recognized all Saps, but the capacity of
human monocytes to secrete IL-1, TNF-, and IL-6 varied in
response to different Saps. In particular, Sap1, Sap2, and Sap6
induced significant amounts of IL-1, TNF-, and IL-6. rSap3
was a strong inducer of TNF-, while it was a poor inducer of
IL-1 and IL-6. In contrast, the lipase of M. furfur and pepsin
from porcine gastric mucosa, used as a control, did not cause
significant induction of cytokines (Fig. 1B). A dose-dependent
analysis performed with all rSaps showed that the optimal dose
to stimulate TNF- secretion was around 20 g/ml (Fig. 1B).
Similar results were obtained when additional cytokines, for
example, IL-6 or IL-1, were tested (data not shown). To
exclude the possibility of the production of proinflammatory
cytokines being influenced by LPS contamination, we per-
formed experiments in the presence of polymyxin B (10 g/
ml). The results showed no differences for all proteases tested,
while, as expected, TNF- production induced by LPS was
strongly reduced (Fig. 1C).
To compare a native Sap to the cognate recombinant pro-
tease, we also used purified native Sap2 and a culture super-
natant containing high concentrations of native Sap2. The se-
cretome was collected from the cultures of two strains of C.
albicans (CAF2-1 and CEC987) grown in YCB-BSA medium
for 48 h. Similar production of TNF- was induced by native
and recombinant Sap2 (Fig. 1D). The secretomes of both
strains, diluted 1:10 and 1:100, were tested. The secretome
diluted 1:10 in both cases stimulated the secretion of TNF-
(Fig. 1D).
Preliminary experiments were performed to test for possible
cytotoxicity of rSaps by treating monocytes with the recombi-
nant proteases at doses ranging from 1 to 50 g/ml. We ob-
served no cytotoxicity after 4 h and 18 h of incubation for all
rSaps, except rSap6, which was able to induce cytotoxicity in
40% of cells at a high dose (50 g/ml). Based on the previous
results, a concentration of 20 g/ml was used in the subsequent
experiments. The capacity of rSap1, rSap2, rSap3, and rSap6 to
induce cellular activation was also confirmed by their ability to
induce a Ca2 influx, and rSap1 was the best stimulator (data
not shown).
Given the fact that most, if not all, of the biological effects of
Saps have been attributed to their enzymatic activity (35, 50),
we tested whether induction of inflammatory cytokines in
monocytes was affected by treatment of Saps with pepstatin A,
an aspartic protease inhibitor. Figure 2A shows that the addi-
tion of pepstatin A did not affect the production of TNF- and
IL-6, suggesting that proteolytic activity is not necessary to
cause induction of these cytokines. Since it has been reported
that Saps 1 to 3 have different pH optima for their enzymatic
activity in the pH range of 2.0 to 5.5 (3), we tested the potential
of rSap1, rSap2, and rSap3 to induce cytokine production at
their optimal pHs (pHs 4 and 5). No production of cytokines
was observed at these selected pH values (data not shown).
Therefore, no cytokines were produced when Saps 1 to 3 were
most active. Under these experimental conditions, even LPS
was unable to induce cytokine production. This could be due to
the difficulty of macrophages to accomplish vital biological
functions at these acidic pH values.
Next, we analyzed whether the denaturation and inactivation
of rSaps influenced the stimulation of cytokine production by
monocytes. To this end, Saps were denatured by autoclaving
and then used to stimulate the cells. Denaturation of rSaps
strongly reduced the proinflammatory cytokine production in-
duced by rSap2, rSap3, and rSap6 (Fig. 2B). In particular, the
denaturation of these Saps strongly reduced the production of
TNF- and IL-1, while proinflammatory cytokine induction
by rSap1 was not modified. The induction of cytokine secretion
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was not modified when LPS, whether autoclaved or not, was
used at a dose of 1 g/ml (Fig. 2B). The dose of LPS was
selected by testing TNF release after stimulation with various
doses of LPS (0.001, 0.01, 0.1, 1, and 10 g/ml). The results
showed that the best stimulation occurred at 1 g/ml and 10
g/ml (data not shown).
Receptors of the PAR family are expressed in phagocytic
cells, serve as sensors of serine proteases, e.g., thrombin, mast
cell tryptase, trypsin, and cathepsin G, in these cells (40), and
are considered key initiators of the inflammatory response.
Since sensing via PARs initiates with a proteolytic digest, we
tested the possible involvement of these receptors in the Sap-
induced proinflammatory cytokine production. To this end, we
blocked PAR1, PAR2, and PAR3, which are expressed mainly
FIG. 1. TNF-, IL-6, and IL-1 production from monocytes after stimulation with Candida albicans rSaps. (A) Monocytes were treated with
rSap1, rSap2, rSap3, and rSap6 (20 g/ml), with lipase of M. furfur (20 g/ml), with pepsin from porcine gastric mucosa, or with LPS (1 g/ml)
or were left untreated and then were incubated for 18 h at 37°C. After incubation, supernatants were recovered and tested for the presence of
TNF-, IL-6, and IL-1. (B) Monocytes were treated with different concentrations of rSaps or pepsin, ranging from 1 to 50 g/ml, or were left
untreated and then were incubated for 18 h at 37°C. (C) Monocytes were treated with different rSaps (20 g/ml) and LPS (1 g/ml) in the presence
or absence of 10 g/ml of polymyxin B. (D) Monocytes were treated with native Sap2, rSap2, and culture supernatant. Data are expressed as
means 
 SD for three independent experiments. Statistical analysis was performed with an ANOVA test for multiple comparisons. *, P  0.05;
**, P  0.01 (rSap-treated cells versus untreated cells).
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in monocytes (53), by using a mouse anti-human PAR1 anti-
body directed against the tethered ligand domain and mouse
anti-human antibodies to PAR2 or PAR3, specific for the
cleavage sites. The data obtained showed that the blockage of
PAR1, PAR2, and PAR3 did not affect the production of
TNF-, IL-6, and IL-1 induced by rSap1 (data not shown).
The induction of cytokines by rSaps in the presence of the
aspartic protease inhibitor pepstatin A implied a direct inter-
action of rSaps with monocytic cells. To verify a direct inter-
action of rSaps with human monocytes, the interaction of
FITC-labeled rSaps with monocytes was assayed using flow
cytometry. Sap1 and Sap2, which showed high-level stimula-
tion of proinflammatory cytokines, were chosen for this exper-
iment. The results shown in Fig. 3 indicate a dose-dependent
association of rSap1 and rSap2 with monocytes. Clearly, the
interaction of rSap2 with cells was greater than that of rSap1.
Both Saps showed similar kinetics of association, reaching a
plateau within 1 day and maintaining it for 4 days, after which
the level declined, to become undetectable after 7 days of
incubation. This could be due to degradation or extrusion of
rSaps. Because the CTLA-4 receptor is not expressed on
monocytes, FITC-conjugated CTLA-4 F(ab)2 was used as a
negative control. This protein was not found to be associated
with the cells at any tested concentration (Fig. 3).
The PI3K-Akt network mediates intracellular signals to reg-
ulate a variety of cellular responses, including cellular activa-
tion, protein synthesis, cell cycling, and survival (6, 39). Given
that PI3K is involved in the signal transduction pathway asso-
ciated with cell activation (15), we considered the possibility
that Sap-induced activation may be related to phosphatidylino-
sitol phosphate (PIP3) recruitment. Since recent evidence in-
dicates that PI3K-dependent activation of Akt is linked to an
increase of PI3K activity (15), we evaluated Akt and 	 phos-
phorylation in cells stimulated with different rSaps. Monocytes
treated with rSap1, rSap2, rSap3, or rSap6 for 1 h showed
increased activation of pAkt compared to unstimulated cells
(Fig. 4A).
Since Akt has been implicated in regulating the activation of
proinflammatory cytokine genes (8, 11), we investigated
whether rSap-mediated activation of proinflammatory cyto-
kines in monocytes occurs via phosphorylation of I	B, which
would allow the translocation of NF-	B into the nucleus (23).
After 4 h of coincubation of monocytes with rSap1, rSap2,
rSap3, and rSap6, activation of I	B was observed (Fig. 4B),
and the latter was related to gene transcription of proinflam-
matory cytokines (26). As a negative control, pepsin was used
FIG. 2. Effects of heat inactivation of Saps, pepstatin A treatment,
and anti-human PAR antibodies on cytokine production induced by
Saps. Monocytes were treated with rSap1, rSap2, rSap3, and rSap6 (20
g/ml) in combination with pepstatin A (15 M) (A) or with heat-
inactivated rSap1, rSap2, rSap3, rSap6, or LPS (1 g/ml) (B). (C) Ef-
fect of pepstatin A (15 M) or heat inactivation of native or recom-
binant Sap2 (20 g/ml) on TNF- production. After incubation,
supernatants were recovered and tested for the presence of TNF-,
IL-1, or IL-6. Data are expressed as means 
 SD for three indepen-
dent experiments. Statistical analysis was performed with an ANOVA
test. *, P  0.05 (heat-inactivated rSap-treated cells versus rSap-
treated cells).
FIG. 3. Association of FITC-Saps with monocytes. Monocytes
treated with different concentrations of FITC-labeled rSap1 or rSap2
or with FITC-conjugated CTLA-4 F(ab)2 for different times were
analyzed by flow cytometry to assess rSap binding. FITC-rSap or
FITC–CTLA-4 F(ab)2 binding by monocytes is expressed as the mean
fluorescence intensity (MIF). Data are expressed as means 
 SD for
three independent experiments.
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in parallel experiments. This aspartic protease was found to be
unable to affect Akt and I	B pathways (Fig. 4C).
Wortmannin is known to be a potent inhibitor of the PIP3-
Akt pathway (38, 43), so we evaluated whether the treatment
of monocytes coincubated with wortmannin was able to inhibit
the secretion of proinflammatory cytokines. Indeed, 5 M
wortmannin drastically reduced IL-1, TNF-, and IL-6 secre-
tion in rSap-treated monocytes (Fig. 5).
Taken together, our results indicate that Saps stimulate cy-
tokine production independently of their enzymatic activity
and that signal transduction is mediated via Akt.
DISCUSSION
Candida infections are a clinical problem of growing impor-
tance. The incidence of infections has grown dramatically over
the past 2 to 3 decades, and it is very likely that this trend will
continue in the years to come. C. albicans is the most common
fungal pathogen and is the fourth leading cause of nosocomial
infections (28, 45), with a high mortality rate for systemic
infection (61). A variety of fungal virulence attributes are in-
volved in the infection process, and some of these attributes
are thought to have distinct roles during infection; for example,
FIG. 4. pAkt and pI	B expression in monocytes treated with Saps.
Monocytes were left untreated or were stimulated with rSap1, rSap2,
rSap3, or Sap6 (20 g/ml) (A and B) or with pepsin (20 g/ml) (C) for
4 h. After incubation, cells were fixed in 3% paraformaldehyde, per-
meabilized in 0.1% saponin, and incubated with rabbit anti-human
phospho-Akt or phospho-I	B and with TRITC-conjugated goat anti-
rabbit IgG. Fluorescent cells were analyzed by cytofluorimetric analysis
and are expressed as the mean fluorescence intensity (MIF). Data are
representative of three independent experiments with similar results.
FIG. 5. Effect of Akt signaling inhibition on cytokine production
induced by rSaps. Monocytes were left untreated or were pretreated
with 5 M wortmannin for 40 min and then treated with rSap1, rSap2,
rSap3, or rSap6 (20 g/ml) or with LPS (1 g/ml) for 18 h at 37°C.
After incubation, supernatants were recovered and tested for the pres-
ence of TNF-, IL-6, and IL-1. Data are expressed as means 
 SD
for three independent experiments. Statistical analysis was performed
with an ANOVA test for multiple comparisons. *, P  0.05; **, P 
0.01 (rSap-plus-wortmannin-treated cells versus rSap-treated cells).
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Sap proteases have the potential to degrade tissue barriers
during invasion, to inactivate host defense molecules, or to
digest host proteins for nutrient supply (35). Many aspects of
their activities have been studied, and it has been proposed
that some particular Saps may be required and optimized for
certain host niches and different stages of infection (36). In-
deed, different members of the Sap family are known to be
active at a broad range of pH values, ranging from pH 2.0 to
6.5; therefore, C. albicans provides proteases for a broad range
of host niches (50).
Here we report that different Saps show differing abilities to
induce secretion of proinflammatory cytokines by human
monocytes. In particular, Sap1, Sap2, and Sap6 strongly in-
duced upregulation of IL-1, TNF-, and IL-6, while Sap3 was
able to stimulate the secretion of IL-1 and TNF-. The treat-
ment of Saps with pepstatin A did not diminish their ability to
induce cytokine secretion, and consequently, the stimulatory
effect of Saps was independent from their proteolytic activity.
Sap-induced inflammatory cytokine production was also inde-
pendent from PAR activation and from the optimal pH for Sap
activity, confirming that cytokine stimulation does not corre-
late with activity. Stimulation of cytokine production by mono-
cytes seems to be regulated via NF-	B, since Saps induced Akt
activation and phosphorylation of I	B, which initiates trans-
location of NF-	B into the nucleus (63).
Previous studies showed that Saps are important virulence
factors of Candida albicans during mucosal and disseminated
infections and may also contribute to the induction of an in-
flammatory host immune response (50). In particular, it has
been shown that mutants lacking either SAP1 or SAP2 caused
reduced tissue damage in a model of vaginal infections using
reconstituted human vaginal epithelium (RHVE) and had a
significantly reduced potential to stimulate cytokine expression
(49). In contrast, mutants lacking SAP4 to SAP6 induced sim-
ilar levels of cytokines to those in the wild-type strain. Addition
of the aspartic protease inhibitor pepstatin A strongly reduced
the cytokine response evaluated in the RHVE model (49, 51).
In our study, we documented a strong ability of Sap1, Sap2,
and Sap6 to induce inflammatory cytokines, and these data
seem to be consistent with the low capacity to induce inflam-
mation of Sap null mutants lacking either SAP1 or SAP2 (51).
However, in contrast with previous results (44), we were un-
able to mitigate the cytokine production by using pepstatin.
There are at least two different explanations for these differ-
ences. First, the reduced induction of inflammation of Sap null
mutants was associated with reduced tissue damage, which very
likely also influenced the level of cytokine expression. We
therefore propose that the previous induction of inflammation
was induced primarily by fungal cells and their activity. Second,
the previous study was based on epithelial cells only, while in
this study human primary monocytes were analyzed.
Therefore, we report in this study, for the first time, that
Saps are potent inducers of inflammatory cytokines, indepen-
dent of their proteolytic activity. This view was supported by
the observation that cytokine induction was independent from
pH values necessary for optimal Sap activity. We therefore
concluded that the antigenic structure of Saps caused the cy-
tokine induction, a phenomenon previously observed for other
virulence factors of C. albicans, such as the mannoprotein
MP65, a well-known adhesin (42, 48). This conclusion is sup-
ported by the fact that heat denaturation of Sap proteins, and
thus destruction of the antigenic structure, greatly mitigated
proinflammatory cytokine release. However, the stimulatory
activity of Sap1 appeared to be unaffected by heat treatment.
This suggests that the stimulatory antigenic components of
Sap2, Sap3, and Sap6 are heat labile, while these structures are
heat stable in Sap1. Such immunogenic stability is consistent
with earlier research indicating that the recognition of albu-
min, one of the most widely studied proteins, is only partially
correlated with its native three-dimensional structure. Indeed,
heat treatment and chemical denaturation (SDS treatment) of
albumin are not able to significantly decrease its capability to
bind to specific antibodies (44). Indeed, in our experimental
system, Sap1 was the best stimulator of proinflammatory cyto-
kine production. A possible explanation could be related to the
different associations of rSaps with human cells, which may be
crucial for inducing different levels of immunoregulation.
Our data indicate that Saps either bind to or are taken up by
monocytes. This interaction of monocytes with rSaps was op-
timal within 1 to 4 days of incubation. After that time, the cells
lost their capacity to bind to or take up Saps, suggesting either
that Saps were degraded or extruded from cells after 7 days or
that monocytes ceased their activity after day 4.
Given that the effects obtained with rSap2 were very similar
to those obtained with native Sap2 and a culture supernatant
from a C. albicans strain that contains a high level of Sap2, it
seems feasible that these effects may also occur in vivo. More-
over, even though we do not know the exact concentrations of
Saps secreted during infection, it is likely that high concentra-
tions can be reached locally.
Serine proteases such as chymotrypsin and trypsin are re-
leased from host cells during inflammation and were originally
thought to be primarily responsible for protein degradation.
Different serine proteases differ in substrate specificity. For
example, chymotrypsin prefers an aromatic side chain on the
residue whose carbonyl carbon is part of the peptide bond to
be cleaved. Trypsin prefers a positively charged Lys or Arg
residue at this position. Recently, however, it was discovered
that these proteases also function as signaling molecules
through the activation of specialized G-protein-coupled recep-
tors called PARs. So far, four PARs have been identified
(PAR1 to -4) and have been detected in numerous cell types,
including cells actively involved in the inflammatory response,
such as neutrophils, and macrophages. PARs have a unique
mechanism of receptor activation, since they all contain a
serine protease cleavage site within the extracellular N termi-
nus. Cleavage of this site results in the unmasking of a tethered
ligand sequence which can then bind to and activate the re-
ceptor. The inflammatory activity induced by Saps was inde-
pendent from PAR activation and, in particular, from PAR1,
PAR2, and PAR3. These results support and extend the evi-
dence given in a previous study in which PAR antagonists were
unable to reverse the potentiation of cytokine production in-
duced by soluble factors released by C. albicans (7).
The PI3K-Akt network mediates intracellular signals, which
implies a variety of cellular responses, including cellular acti-
vation (6, 39). Given that PI3K is involved in the signal trans-
duction pathway associated with cell activation (15), we con-
sidered the possibility that Sap-mediated activation might
imply PI3K recruitment. Recent evidence indicates that PI3K-
4760 PIETRELLA ET AL. INFECT. IMMUN.
 o
n
 February 11, 2013 by Universiteitsbibliotheek
http://iai.asm
.org/
D
ow
nloaded from
 
dependent activation of Akt is synonymous with increased
PI3K activity (15). Indeed, the activation of Sap-induced Akt
implies that the signal triggered by Saps is via activation of
PIP3, which binds to and activates the phosphoinositide-de-
pendent protein kinase 1. This, in turn, phosphorylates and
activates the downstream target Akt, which can then activate
the NF-	B pathway. Therefore, Saps trigger the Akt/NF-	B
pathway, which is known to regulate the gene transcription of
inflammatory cytokines. This assumption was corroborated by
the capacity of wortmannin, a PIP3-Akt pathway inhibitor, to
completely block the Sap-induced production of cytokines such
as IL-1, TNF, and IL-6.
Taken together, these results reveal that the Sap-induced
inflammatory response is independent from both enzymatic
activity and PAR activation. In addition, Sap-induced inflam-
mation is dependent on the antigenic structure and is triggered
by the Akt/NF-	B activation pathway. This newly discovered
immunoregulatory aspect sheds light on C. albicans virulence
traits.
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